Recombinant CD20 (Veltuzumab Biosimilar) antibody
The Humanized Monoclonal anti-CD20 (Veltuzumab Biosimilar) antibody (ABIN7538083) specifically detects CD20 (Veltuzumab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN7538083
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CD20 (Veltuzumab Biosimilar) antibody (ABIN7538083)
Target
CD20 (Veltuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This CD20 (Veltuzumab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Veltuzumab Biosimilar - Anti- CD20 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD20 (Veltuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL).
-
CAS-No
- 728917-18-8
Target
-
You are here:
